Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
3
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alnylam pharmaceuticals
biomarin pharmaceutical
biotech
celgene
deals
gene therapy
hemophilia
pharmacy benefit managers
sangamo therapeutics
2019
activism
acute hepatic porphyria
administration
alzheimer's
What
bio
gene
roundup
3
×
therapy
3
×
drug
moves
patients
advanced
alnylam’s
approval
aren’t
becker
bff
billions
conference
deals
developers
devoted
disease
dollars
drugs
easl
eaton
fda
form
healthcare
help
imminent
impact
kicked
life
liver
long
major
medicare
michael
millions
news
noteworthy
prices
Language
Current search:
roundup
×
therapy
×
" detroit top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More